FORM 5

[__] Check box if no longer
      subject to Section 16. Form 4 or Form
      5 obligations may continue.
      See Instruction 1(b).


[__]  Form 3 Holdings Reported
[__]  Form 4 Transactions Reported

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility
Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL



OMB Number: 3235-0362
Expires: January 31, 2005
Estimated average burden
hours per response. . . . 1.0
1. Name and Address of Reporting Person*
   Ruckelshaus, William D

(Last)                      (First)                      (Middle)

  100 Route 206 North

(Street)

  Peapack, NJ 07977

(City)                      (State)                      (Zip)

2. Issuer Name and Ticker
    or Trading Symbol

   Pharmacia - PHA

3. I.R.S. Identification
    Number of Reporting
    Person, if an entity
    (Voluntary)

     
4. Statement for
    (Month/Year)

   12/2002


5. If Amendment,
    Date of Original
    (Month/Year)

    
6. Relationship of Reporting Person(s) to Issuer
(Check all applicable)


   X    Director                                __   10% Owner

  __   Officer (give title below)        __   Other (specify below)

         

7. Individual or Joint/Group Reporting
    (check applicable line)

  _ X    Form Filed by One Reporting Person

  ____    Form Filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security
    (Instr. 3)

2. Transaction Date
    (Month/Day/Year)
2A. Deemed
      Execution
      Date,
      if any (Month/
      Day/ Year)
3. Transaction Code
    (Instr. 8)

4. Securities Acquired (A) or Disposed of (D)  
    (Instr. 3, 4 and 5)
5. Amount of
    Securities
    Beneficially
    Owned at the end of
    Issuer's Fiscal Year
    (Instr. 3 and 4)
6. Ownership
    Form:
    Direct (D)
    or Indirect (I)
    (Instr. 4)
7.   Nature of
     Indirect
     Beneficial
     Ownership
     (Instr. 4)
Amount (A) or (D) Price           

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).


Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
    (Instr. 3)
2. Conver-
    sion or
    Exercise
    Price of
    Deri-
    vative
    Security
3. Transaction
    Date  (Month/
    Day/ Year)
3A. Deemed
      Execution Date,
      if any (Month/
      Day/ Year)
4. Transaction Code     
    (Instr. 8)

5. Number of
    Derivative
    Securities
    Acquired (A)
    or Disposed of (D)
    (Instr. 3, 4 and 5)

6. Date Exercisable and
    Expiration Date
    (Month/Day/Year)
7. Title and Amount
    of  Underlying
    Securities
    (Instr. 3 and 4)
8. Price of
    Derivative
    Security
    (Instr. 5)
9. Number of
    Derivative
    Securities
    Beneficially
    Owned
    at End of
    Year
    (Instr. 4)
10. Ownership of      Derivative
     Security:
     Direct (D)
     or Indirect (I)
     (Instr. 4)
11. Nature of
      Indirect
      Beneficial
      Ownership
      (Instr. 4)
(A) (D) Date
Exercisable
Expiration
Date
Title Amount or
Number of
Shares
Stock Equivalent Units1 for 106/18/2002 A1,744 (1)   Common1,744$40.136,705 (2)D 

Explanation of Responses:  (1) Stock Equivalent Units acquired through the Directors’ Equity Compensation and Deferral Plan.
     (2) Includes reinvested dividends.
     


            /s/ Don W. Schmitz, attorney-in-fact for William D. Ruckelshaus                     01/24/2003    ** Signature of Reporting Person Date

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
        See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note:   File three copies of this Form, one of which must be manually signed. If space is insufficient,
            see Instruction 6 for procedure.